CEMI.OB: Summary for CHEMBIO DIAGNOSTICS - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 1:54am EST - Canadian Markets open in 7 hours and 36 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Chembio Diagnostics, Inc. (CEMI.OB)

On Nov 24: 0.31 USD

0.01 (3.13%)

MORE ON CEMI.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CHEMBIO DIAGNOSTICS (OTC BB:CEMI.OB) Delayed quote data

Last Trade:	0.31 USD
Trade Time:	Nov 24
Change:	0.01 (3.13%)
Prev Close:	0.32
Open:	0.32
Bid:	0.31 x 5000
Ask:	0.32 x 5000
1y Target Est:	0.50

Day's Range:	0.30 - 0.32
52wk Range:	0.08 - 0.57
Volume:	140,988
Avg Vol (3m):	41,450
Market Cap:	19.20M
P/E (ttm):	N/A
EPS (ttm):	-0.01
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add CEMI.OB to Portfolio

Download Data

HEADLINES

•	CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Tue, Nov 17)

•	Chembio Diagnostics to Present at the FDA Blood Products Advisory Committee on November 17, 2009
	Marketwire (Tue, Nov 17)

•	CHEMBIO DIAGNOSTICS, INC. Financials
	EDGAR Online Financials (Tue, Nov 10)

•	CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Wed, Nov 4)

•	Chembio Reports Third Quarter 2009 Results
	Marketwire (Wed, Nov 4)

•	CHEMBIO DIAGNOSTICS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Wed, Nov 4)

•	Q3 2009 CHEMBIO DIAGNOSTICS INC Earnings Release - After Market Close
	CCBN (Wed, Nov 4)

•	CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Wed, Oct 28)

•	Chembio to Host Conference Call to Discuss Third Quarter 2009 Financial Results
	Marketwire (Tue, Oct 27)

•	CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Tue, Oct 20)

More Headlines for CEMI.OB...

ANALYST

EPS Est (next year) (Dec-08) :	N/A
EPS Est (in 2 years) (Dec-09) :	N/A
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and markets rapid diagnostic tests for the detection of HIV antibodies in whole blood, serum, and plasma samples.

Full Company Profile

Add to Portfolio

Email to a Friend

•